Please see below for a list of search results.
The HTA would like to thank establishments in the HA sector for the prompt completion and return of the HA sector COVID-19 questionnaire at such a challenging time.
Transplant units and Stem Cell coordinators must use the updated template referral letter when referring a case to the HTA.
Download the updated template referral letter (DOC 45 KB)
The Department of Health and Social Care has published guidance for industry and organisations involved in health and care about plans for a no-deal Brexit.
The Human Tissue Authority (HTA) is aware that Precious Cells International (PCI) entered liquidation on Friday 23 November. The Official Receiver has been appointed as the liquidator.
The Human Tissue Authority (HTA) has been made aware that two HTA-licensed establishments are to enter administration. These two services are Precious Cells International Ltd and
These guides set out your basic rights when dealing with an establishment regulated by the HTA.
The HTA was asked to share a letter written to the University of Bristol regarding a process taking place at the university in 2008, as part of a process to create an artificial trachea for transplant
The Human Tissue Authority (HTA) welcomes the publication of the report from the Regenerative Medicine Expert Group, “Building on our own potential: a UK pathway for regenerative medicine”.